Navigation Links
Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
Date:11/5/2013

NEW YORK, Nov. 5, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement with Huons Co, Ltd. (KOSDAQ: 84110), a leading Korean pharmaceuticals company. The agreement formalizes the strategic partnership between the parties and gives Aquavit the worldwide, perpetual, and unlimited license for global commercialization of a cutting-edge drug-delivery system.

The two companies will be investing up to 20 Million USD to further develop the technology and bring to market the highest standard, GMP manufactured product innovations.

"It is a very exciting technology extension for Aquavit. I can already think of many applications and possibilities," said Dr. Nark K. Roh, a world renowned dermatologist and Medical Director of Leaders Clinic.

Aquavit's integrated platform includes innovative microneedle technology, first-of-its-kind desktop robotics for real-time formulations, and proprietary and personalized compounds and admixtures tied together by an advanced health informatics technology. Recently, Aquavit showcased its platform technology at the Big Data in Pharma Conference (Big Dip 2013) opening the Big Data Applications Session.

Earlier this year, Aquavit in-licensed its first microneedle delivery system, AQT-001 branded as AQUAGOLD® fine touch™. Aquavit holds the perpetual, exclusive, worldwide right to license, sub-license, improve and/or commercialize the AQT series and all derivative intellectual property. The AQT series has FDA, CE Mark and KFDA registration and will commerce global distribution in early 2014.

"We look forward to unveiling this latest technology to the public at the 72nd American Academy of Dermatology Annual Meeting in Denver in March, 2014. We aim to be a leader in personalized treatment options integrating cutting-edge technology, assessment tools, and knowledge of our key opinion leaders," said Sobin Chang, CEO of Aquavit.

About Huons Co., Ltd.
Huons Co, Ltd. (KOSDAQ: 84110) is a leading Korean pharmaceuticals company focusing in the development and distribution of drugs, medical devices and regulated cosmetics. It's areas of strength are Urology Orthopedic Surgery, Anti-Arthritis, Anesthetics, Natural Well-Being Products including Anti-Obesity, Gynecology and related Women's Health and Dental Care. For more information, visit www.huons.com.   

About Aquavit Pharmaceuticals, Inc.
Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical device, and health technologies adapted for the new personalized health paradigm. For more information, visit www.aquavitpharma.com.


'/>"/>
SOURCE Aquavit Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit Pharmaceuticals and U-Bio Med Enter Exclusive Worldwide License Agreement for Microneedle Technology (AQT-001)
2. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
3. Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
4. Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia
5. Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12
6. Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange
7. Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11
8. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
9. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
10. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
11. Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc ... reached agreements to resolve virtually all known U.S. mesh ... discussions to resolve the known remaining U.S. claims at ... payments beginning in the fourth quarter of 2017 and ... of its second quarter 2017 results, the Company intends ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
Breaking Medicine Technology:
(Date:8/18/2017)... York (PRWEB) , ... August ... ... LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics provider ... has entered into a definitive agreement to purchase Unitrans International Corporation, a ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, Eppendorf ... they will present the line of epMotion automated liquid handling system. This automated ... automate everyday pipetting tasks. , Ideal for scientists and lab technicians with no ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a ... throughout the greater DC region, is inaugurating a “New Leash On Life” charity ... and training them to be companions for veterans in need. , The Semper ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a ... in east Texas, is launching a regional charity effort to provide publicity assistance ... the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations ...
Breaking Medicine News(10 mins):